SELECTIVE NR2B ANTAGONISTS

The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands of the NR2B receptor and may be useful for the treatment of various disorders of the central nervous system.

Saved in:
Bibliographic Details
Main Authors Cheruku, Srinivas, Macor, John E, Warrier, Jayakumar Sankara, Islam, Imadul, Thangathirupathy, Srinivasan, Shetty, Poornima, Gupta, Grandhi Venkat Ram Krishna Mohan
Format Patent
LanguageEnglish
Published 01.11.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands of the NR2B receptor and may be useful for the treatment of various disorders of the central nervous system.
Bibliography:Application Number: US201615767386